EUVIMEDEUVIMED entdecken
Open Access

NSUN2-mediated m 5 C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2/SRSF6/UAP1 signaling axis

Xiukun Hou, Qiman Dong, Jie Hao, Min Liu, Junya Ning, Mei Tao, Zhongyu Wang, Fengli Guo, Dongmei Huang, Xianle Shi, Ming Gao, Dapeng Li und 1 weitere

Theranostics · 27.01.2025 · 15 (7) · 2757-2777

DOI: 10.7150/thno.104713 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 27.01.2025. Verfasst von Xiukun Hou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Neck Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key La…. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Alternative Splicing, Drug Resistance, Neoplasm, Thyroid Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Carcinoma, AnaplasticAlternative SplicingDrug Resistance, NeoplasmThyroid NeoplasmsSerine-Arginine Splicing FactorsDrug Resistance, MultipleHumansAnimalsMiceCell Line, TumorSignal TransductionRNA-Binding ProteinsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

5-methylcytosineNSUN2alternative splicing reprogramminganaplastic thyroid cancermultidrug resistance

Substanzen

Serine-Arginine Splicing FactorsRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Thyroid and Neck Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research…
  • Department of Thyroid and Breast Surgery, Tianjin Union Medical Center, Tianjin 300121, China.
  • Tianjin Key Laboratory of General Surgery in Construction, Tianjin Union Medical Center, Tianjin 300121, China.
  • School of Medicine, Nankai University, Tianjin 300071, China.

Zitieren

APA

Hou, X., Dong, Q., Hao, J., Liu, M., Ning, J., Tao, M., Wang, Z., Guo, F., Huang, D., Shi, X., Gao, M., Li, D., & Zheng, X. (2025). NSUN2-mediated m 5 C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2/SRSF6/UAP1 signaling axis. Theranostics, 15(7), 2757-2777. https://doi.org/10.7150/thno.104713

Vancouver

Hou X, Dong Q, Hao J, Liu M, Ning J, Tao M, et al. NSUN2-mediated m 5 C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2/SRSF6/UAP1 signaling axis. Theranostics. 2025;15(7):2757-2777. doi:10.7150/thno.104713

BibTeX
@article{Hou2025,
  author = {Hou, Xiukun and Dong, Qiman and Hao, Jie and Liu, Min and Ning, Junya and Tao, Mei and Wang, Zhongyu and Guo, Fengli and Huang, Dongmei and Shi, Xianle and Gao, Ming and Li, Dapeng and Zheng, Xiangqian},
  title = {NSUN2-mediated m 5 C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2/SRSF6/UAP1 signaling axis},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {2757--2777},
  doi = {10.7150/thno.104713}
}
Kostenlos starten →